Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 3092

BillFederalSenateIn Committee
A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the 180-day exclusivity period, and for other purposes.
About This Bill
Committee
Latest Action · December 18, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congress
116th (2019–2021)
Introduced
December 18, 2019
Cosponsors (1)
0D 1R
View PDF ↗

Summary

Highlight any text to annotate
Expanding Access to Low-Cost Generics Act of 2019 This bill modifies the 180-day exclusivity period for certain generic drug manufacturers.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.